Profiles of Common and Unique aspects of Upper Motor Neuron degeneration in HSP and ALS

HSP 和 ALS 上运动神经元变性的共同和独特方面的概况

基本信息

项目摘要

ABSTRACT/ PROJECT SUMMARY: The movement starts in the brain. Especially for motor neuron diseases, which impact voluntary movement, the brain component requires better understanding and assessment. Upper motor neurons (UMNs), located in layer 5 of the motor cortex, have a unique role for the initiation and modulation of voluntary movement. Their progressive degeneration is the characteristic hallmark of neuropathology observed in hereditary spastic paraplegia (HSP) and amyotrophic lateral sclerosis (ALS) patients. In striking contrast to their clinical importance and relevance, very little is known about the underlying causes of their vulnerability and progressive loss. This lack of information and understanding of the cellular and genetic basis of their vulnerability, as well as the common and unique aspects of their neurodegeneration hinders our ability to develop effective and long-term treatment strategies for diseases of the UMN. In an effort to bring a mechanistic insight into the cellular and molecular basis of UMN degeneration in two distinct diseases, such as HSP and ALS, we are going to take advantage of the UCHL1-eGFP mice, a reporter line in which the UMNs are genetically labeled with fluorescence. In this proposal, we will focus our attention to the Profilin and Spastin, because like Spastin, Profilin is an actin/tubulin-binding protein, and mutations in profilin results in ALS, whereas mutations in spastin results in HSP. To date numerous mouse models are generated to mimic the human condition. We crossed the hPFN1G118V (generated by Dr. Kiaei) and SPASTC448Y mice (generated by Dr. Baas) with UCHL1-eGFP mice to generate the UMN reporter lines with these mutations. Since we have shown that the UMNs of ALS patients with TDP-43 pathology and mouse UMNs of TDP-43 model share the same aspects of neurodegeneration at a cellular level, we will focus our attention to the neurons and purify diseased UMNs from the complex structure of the brain as a “pure” neuron population at different stages of the disease to investigate the dynamic changes in their gene expression profile as well as the proteins that are present in them, with respect to the healthy UMNs. As an internal control, we will use UMNs isolated from TDP- 43 mouse model not only because TDP-43 pathology is widely observed in ALS and HSP, but also because this model better represents the spectrum of ALS. Upon completion, our results will begin to reveal the common and unique aspects of UMN vulnerability in HSP and ALS, it will also suggest the distinct set of genes and/or proteins that are responsible for the initiation of their vulnerability. Most importantly our results have the potential to identify druggable targets and pathways of interest for future therapeutic interventions.
摘要/项目概述:

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Pembe Hande Ozdinler其他文献

Pembe Hande Ozdinler的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Pembe Hande Ozdinler', 18)}}的其他基金

Novel Protein Aggregation Inhibitors and Upper Motor Neuron Stabilizers for ALS and other Neurodegenerative Diseases
用于治疗 ALS 和其他神经退行性疾病的新型蛋白质聚集抑制剂和上运动神经元稳定剂
  • 批准号:
    10624425
  • 财政年份:
    2019
  • 资助金额:
    $ 44万
  • 项目类别:
Administrative Supplement - Novel Protein Aggregation Inhibitors and Upper Motor Neuron Stabilizers for ALS and other Neurodegenerative Diseases
行政补充 - 用于 ALS 和其他神经退行性疾病的新型蛋白质聚集抑制剂和上运动神经元稳定剂
  • 批准号:
    10451057
  • 财政年份:
    2019
  • 资助金额:
    $ 44万
  • 项目类别:
Novel Protein Aggregation Inhibitors and Upper Motor Neuron Stabilizers for ALS and other Neurodegenerative Diseases
用于治疗 ALS 和其他神经退行性疾病的新型蛋白质聚集抑制剂和上运动神经元稳定剂
  • 批准号:
    10403947
  • 财政年份:
    2019
  • 资助金额:
    $ 44万
  • 项目类别:
The role of UCHL1 on the health and stability of upper motor neurons
UCHL1对上运动神经元健康和稳定性的作用
  • 批准号:
    8613024
  • 财政年份:
    2013
  • 资助金额:
    $ 44万
  • 项目类别:
The role of UCHL1 on the health and stability of upper motor neurons
UCHL1对上运动神经元健康和稳定性的作用
  • 批准号:
    8731288
  • 财政年份:
    2013
  • 资助金额:
    $ 44万
  • 项目类别:
Genetic labeling and visualization of CSMN in models of motor neuron disorders
运动神经元疾病模型中 CSMN 的基因标记和可视化
  • 批准号:
    8623379
  • 财政年份:
    2013
  • 资助金额:
    $ 44万
  • 项目类别:
The role of UCHL1 on the health and stability of upper motor neurons
UCHL1对上运动神经元健康和稳定性的作用
  • 批准号:
    8877655
  • 财政年份:
    2013
  • 资助金额:
    $ 44万
  • 项目类别:
Genetic labeling and visualization of CSMN in models of motor neuron disorders
运动神经元疾病模型中 CSMN 的基因标记和可视化
  • 批准号:
    8731290
  • 财政年份:
    2013
  • 资助金额:
    $ 44万
  • 项目类别:

相似海外基金

Whole Genome Sequencing to identify novel loci in French Canadian ALS patients
全基因组测序识别法裔加拿大 ALS 患者的新基因座
  • 批准号:
    387259
  • 财政年份:
    2017
  • 资助金额:
    $ 44万
  • 项目类别:
    Studentship Programs
Elucidation of the optimal period of PAP therapy aiming at oral ingestion by ALS patients.
阐明针对 ALS 患者口服摄入的 PAP 治疗的最佳时期。
  • 批准号:
    19K20753
  • 财政年份:
    2016
  • 资助金额:
    $ 44万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
The effect of TNF-alpha on microglial induced hyperexcitation in cortical neurons of ALS patients
TNF-α对ALS患者皮质神经元小胶质细胞过度兴奋的影响
  • 批准号:
    367192
  • 财政年份:
    2016
  • 资助金额:
    $ 44万
  • 项目类别:
    Studentship Programs
Study of a communication support system for ALS patients based on changes in cerebral ongoing activity
基于大脑持续活动变化的ALS患者沟通支持系统研究
  • 批准号:
    15K12605
  • 财政年份:
    2015
  • 资助金额:
    $ 44万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Comprehensive genetic analysis of ALS-related genes in Japanese sporadic ALS patients
日本散发性ALS患者ALS相关基因综合遗传分析
  • 批准号:
    15K19485
  • 财政年份:
    2015
  • 资助金额:
    $ 44万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
ALS4 mice show TDP-43 protein mislocalization in motor neurons characteristic of sporadic ALS patients; suggesting this model is likely to reveal important patho-mechanistic disease insights
ALS4 小鼠在运动神经元中显示 TDP-43 蛋白错误定位,这是散发性 ALS 患者的特征;
  • 批准号:
    nhmrc : 1045520
  • 财政年份:
    2013
  • 资助金额:
    $ 44万
  • 项目类别:
    NHMRC Project Grants
Study of restoration process of the living environments of bereaved families that had undertaken long-term at-home care for ALS patients
长期居家护理ALS患者家属生活环境恢复过程研究
  • 批准号:
    24760510
  • 财政年份:
    2012
  • 资助金额:
    $ 44万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Microarray analysis in spinal cords of sporadic ALS patients with cell-type specific transcriptome
散发性 ALS 患者脊髓中细胞类型特异性转录组的微阵列分析
  • 批准号:
    24591259
  • 财政年份:
    2012
  • 资助金额:
    $ 44万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A pathological study of impaired cytoplasmic-nuclear transport impairment infamilial ALS patients harboring FUS mutatio
携带FUS突变的家族性ALS患者细胞质-核转运受损的病理学研究
  • 批准号:
    23790997
  • 财政年份:
    2011
  • 资助金额:
    $ 44万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
MODEL FOR THE PROMOTION OF A BARRIER-FREE MIND IN THE FAMILY CAREGIVER OF ALS PATIENTS
促进 ALS 患者家庭护理人员无障碍心态的模型
  • 批准号:
    23593266
  • 财政年份:
    2011
  • 资助金额:
    $ 44万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了